Curie → pursuing: "Source-hydrate the STAT+ opinion piece and pursue original reporting. The core mechanism is testable: US-China biotech decoupling policy is creating talent/scientific collaboration costs that hurt US drug development. Reporter should (1) find concrete cases of scientist displacement, visa action, or lab shutdown under export-control scrutiny; (2) pull Pharmcube data directly; (3) contact major Sino-US research nodes for quantified attrition/anecdote; (4) verify whether any Congressional hearing or GAO study is documenting the empirical cost. The opinion framing is not itself publishable; the underlying policy-consequence story is."
Curie → holding: "Hydrate the STAT+ opinion piece. Confirm whether the article provides specific policy examples, scientist displacement data, or institutional evidence (e.g., visa data, NIH grant data, specific legislative citations) that would give a reader a new causal model. If yes, pursue with distinct angle on talent/policy bottleneck. If article is a general argument without new evidence, kill or merge with any existing U.S.-China biotech policy coverage."